Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis

T Meejun, K Srisurapanont, K Manothummetha… - Blood Advances, 2023 - Elsevier
Immunogenicity of SARS-CoV-2 vaccination is diminished in hematopoietic stem cell
transplant (HSCT) recipients. To summarize current evidence and identify risk factors for …

Impact of SARS-CoV-2 Infection on Humoral and Cellular Immunity in a Cohort of Vaccinated Solid Organ Transplant Recipients

B Ayala-Borges, M Escobedo, N Egri, S Herrera… - Vaccines, 2023 - mdpi.com
The aim of the present study was to determine humoral and T-cell responses after four
doses of mRNA-1273 vaccine in solid organ transplant (SOT) recipients, and to study …

[PDF][PDF] Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine

L Barabino, A Galitzia, R Murru… - Eur Rev Med …, 2023 - europeanreview.org
6915 previously responded to the second dose had a seroconversion, with a median IgG
SARS-CoV-2 titer of 1,230 (403-2,080) BAU/mL. Only one patient did not experience an …

RESPOSTA IMUNE GERADA PELA VACINAÇÃO CONTRA COVID-19 EM INDIVÍDUOS IMUNO-COMPROMETIDOS: UMA REVISÃO NARRATIVA DE LITERATURA …

IM de Assis, FG Botaro, ALM Duarte… - ULAKES JOURNAL …, 2024 - revistas.unilago.edu.br
A COVID-19 é uma doença infecciosa considerada um importante problema de saúde
pública. A infecção pelo vírus SARS-CoV-2 desencadeia diversas manifestações clínicas …

[PDF][PDF] Supplement Online Content

O MEDLINE - scienceopen.com
8.(BNT162b2 or Pfizer or BioNTech or Comirnaty or Tozinameran). mp. 9.(CoronaVac or
Sinovac or PiCoVacc). mp. 10.(mRNA-1273 or Moderna or Elasomeran). mp. 11.((WIV04 …